🚀 VC round data is live in beta, check it out!
Astrana Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Astrana Health and similar public comparables like OdontoPrev, Mitra Keluarga, Almoosa Health, Surgery Partners and more.
Astrana Health Overview
About Astrana Health
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company’s three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Founded
1985
HQ
Employees
1.9K
Website
Sectors
Financials (LTM)
EV
$2B
Astrana Health Financials
Astrana Health reported last 12-month revenue of $3B and EBITDA of $223M.
In the same LTM period, Astrana Health generated $376M in gross profit, $223M in EBITDA, and $34M in net income.
Revenue (LTM)
Astrana Health P&L
In the most recent fiscal year, Astrana Health reported revenue of $3B and EBITDA of $205M.
Astrana Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $376M | XXX | $342M | XXX | XXX | XXX |
| Gross Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA | $223M | XXX | $205M | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 6% | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | 2% | XXX | XXX | XXX |
| Net Profit | $34M | XXX | $22M | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $609M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Astrana Health Stock Performance
Astrana Health has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Astrana Health's stock price is $31.47.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 2.8% | XXX | XXX | XXX | $0.40 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAstrana Health Valuation Multiples
Astrana Health trades at 0.7x EV/Revenue multiple, and 10.8x EV/EBITDA.
EV / Revenue (LTM)
Astrana Health Financial Valuation Multiples
As of April 18, 2026, Astrana Health has market cap of $2B and EV of $2B.
Equity research analysts estimate Astrana Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Astrana Health has a P/E ratio of 51.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 10.8x | XXX | 11.7x | XXX | XXX | XXX |
| EV/EBIT | 22.6x | XXX | 30.6x | XXX | XXX | XXX |
| EV/Gross Profit | 6.4x | XXX | 7.0x | XXX | XXX | XXX |
| P/E | 51.2x | XXX | 78.0x | XXX | XXX | XXX |
| EV/FCF | 22.4x | XXX | 23.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Astrana Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Astrana Health Margins & Growth Rates
Astrana Health's revenue in the last 12 month grew by 20%.
Astrana Health's revenue per employee in the last FY averaged $1.7M, while opex per employee averaged $0.1M for the same period.
Astrana Health's rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Astrana Health's rule of X is 70% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Astrana Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 20% | XXX | 25% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Growth | 25% | XXX | 29% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 32% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 70% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.7M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 6% | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | 8% | XXX | 8% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Astrana Health Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Astrana Health | XXX | XXX | XXX | XXX | XXX | XXX |
| OdontoPrev | XXX | XXX | XXX | XXX | XXX | XXX |
| Mitra Keluarga | XXX | XXX | XXX | XXX | XXX | XXX |
| Almoosa Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Surgery Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Astrana Health M&A Activity
Astrana Health acquired XXX companies to date.
Last acquisition by Astrana Health was on XXXXXXXX, XXXXX. Astrana Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Astrana Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAstrana Health Investment Activity
Astrana Health invested in XXX companies to date.
Astrana Health made its latest investment on XXXXXXXX, XXXXX. Astrana Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Astrana Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Astrana Health
| When was Astrana Health founded? | Astrana Health was founded in 1985. |
| Where is Astrana Health headquartered? | Astrana Health is headquartered in United States. |
| How many employees does Astrana Health have? | As of today, Astrana Health has over 1K employees. |
| Who is the CEO of Astrana Health? | Astrana Health's CEO is Brandon K. Sim. |
| Is Astrana Health publicly listed? | Yes, Astrana Health is a public company listed on Nasdaq. |
| What is the stock symbol of Astrana Health? | Astrana Health trades under ASTH ticker. |
| When did Astrana Health go public? | Astrana Health went public in 2007. |
| Who are competitors of Astrana Health? | Astrana Health main competitors are OdontoPrev, Mitra Keluarga, Almoosa Health, Surgery Partners. |
| What is the current market cap of Astrana Health? | Astrana Health's current market cap is $2B. |
| What is the current revenue of Astrana Health? | Astrana Health's last 12 months revenue is $3B. |
| What is the current revenue growth of Astrana Health? | Astrana Health revenue growth (NTM/LTM) is 20%. |
| What is the current EV/Revenue multiple of Astrana Health? | Current revenue multiple of Astrana Health is 0.7x. |
| Is Astrana Health profitable? | Yes, Astrana Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Astrana Health? | Astrana Health's last 12 months EBITDA is $223M. |
| What is Astrana Health's EBITDA margin? | Astrana Health's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Astrana Health? | Current EBITDA multiple of Astrana Health is 10.8x. |
| What is the current FCF of Astrana Health? | Astrana Health's last 12 months FCF is $107M. |
| What is Astrana Health's FCF margin? | Astrana Health's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Astrana Health? | Current FCF multiple of Astrana Health is 22.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.